Bacil Pharma Ltd.
BSE: 524516 | Sector: Health care |
NSE: N.A. | ISIN Code: INE711D01018 |
BSE 00:00 | 09 Apr | 3.96 |
0 (0.00%) |
OPEN
3.96 |
HIGH
3.96 |
LOW
3.96 |
NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
OPEN | 3.96 |
PREVIOUS CLOSE | 3.96 |
VOLUME | 500 |
52-Week high | 6.12 |
52-Week low | 1.57 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 619.15 | 148,552.65 | 12,531.93 | 3,211.14 | 32,355.78 |
Divi's Lab. | 3,783.40 | 100,430.35 | 5,310.57 | 1,372.71 | 7,370.84 |
Dr Reddy's Labs | 4,989.20 | 82,970.40 | 11,850.40 | 2,937.70 | 16,732.90 |
Cipla | 903.00 | 72,822.43 | 12,659.15 | 2,318.17 | 17,704.77 |
Aurobindo Pharma | 916.15 | 53,677.23 | 13,266.48 | 1,872.74 | 16,809.46 |
Cadila Health. | 499.95 | 51,179.88 | 6,347.40 | 1,412.90 | 15,089.80 |
Biocon | 404.10 | 48,492.00 | 1,988.40 | 440.90 | 7,583.50 |
Lupin | 1,045.75 | 47,445.68 | 11,025.66 | 727.55 | 17,937.29 |
Apollo Hospitals | 3,011.90 | 43,305.10 | 9,794.50 | 470.30 | 8,570.00 |
Torrent Pharma. | 2,555.65 | 43,246.71 | 6,168.44 | 938.51 | 10,683.66 |
Gland Pharma | 2,595.70 | 42,465.65 | 2,633.24 | 772.86 | 3,653.86 |
Piramal Enterp. | 1,629.20 | 36,746.61 | 4,219.19 | 144.85 | 33,415.39 |
Alkem Lab | 2,744.70 | 32,812.89 | 6,677.08 | 1,264.42 | 7,728.19 |
Abbott India | 15,058.80 | 31,999.95 | 4,093.14 | 592.93 | 2,691.43 |
Dr Lal Pathlabs | 3,338.70 | 27,824.72 | 1,273.60 | 223.18 | 1,106.64 |
Ipca Labs. | 2,153.75 | 27,320.32 | 4,367.43 | 652.46 | 4,185.23 |
Glaxosmi. Pharma | 1,454.30 | 24,637.30 | 3,224.68 | 110.05 | 2,129.60 |
Laurus Labs | 416.20 | 22,333.29 | 2,797.34 | 267.05 | 2,966.39 |
Syngene Intl. | 550.10 | 22,004.00 | 2,011.90 | 411.50 | 3,313.70 |
Pfizer | 4,761.55 | 21,784.09 | 2,151.65 | 509.13 | 3,534.54 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices